Murilo Freitas – Página 67 – PRAIS 2.0

FDA Warns Four Companies for Selling Tainted Honey-based Products with Hidden Active Drug Ingredients

Murilo Freitas - 14:32, 11 de julio de 2022310

FDA Warns Four Companies for Selling Tainted Honey-based Products with Hidden Active Drug Ingredients
http://www.fda.gov/news-events/press-announcements/fda-warns-four-companies-selling-tainted-honey-based-products-hidden-active-drug-ingredients

FDA Infant Formula Update: July 8, 2022

Murilo Freitas - 19:18, 7 de julio de 2022332

FDA Infant Formula Update: July 8, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-july-8-2022

FDA Roundup: July 8, 2022

Murilo Freitas - 18:50, 7 de julio de 2022308

FDA Roundup: July 8, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-8-2022

FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for U.S. Parents and Caregivers

Murilo Freitas - 18:09, 5 de julio de 2022398

FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for U.S. Parents and Caregivers
http://www.fda.gov/news-events/press-announcements/fda-developing-new-framework-continued-expanded-access-infant-formula-options-us-parents-and

Coronavirus (COVID-19) Update: FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations

Murilo Freitas - 16:35, 5 de julio de 2022369

Coronavirus (COVID-19) Update: FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pharmacists-prescribe-paxlovid-certain-limitations

FDA Infant Formula Update: July 6, 2022

Murilo Freitas - 13:31, 5 de julio de 2022307

FDA Infant Formula Update: July 6, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-july-6-2022

Getinge USA Sales Inc Recalls Flow-c and Flow-e Anesthesia Systems for Cracked or Broken Suction System Power Switches

Murilo Freitas - 04:00, 5 de julio de 2022368

A broken on/off suction switch of the Getinge Flow-c and Flow-e anesthesia systems may prevent fluids from being removed from the patient’s airway.

http://www.fda.gov/medical-devices/medical-device-recalls/getinge-usa-sales-inc-recalls-flow-c-and-flow-e-anesthesia-systems-cracked-or-broken-suction-system

Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Pens

Murilo Freitas - 04:00, 5 de julio de 2022363

Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens which are packaged in cartons of five pens to the consumer level. This product is not the branded Semglee® pen but the un

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-pharmaceuticals-inc-viatris-company-issues-voluntary-nationwide-recall-one-batch-insulin

FDA Roundup: July 5, 2022

Murilo Freitas - 20:17, 4 de julio de 2022309

FDA Roundup: July 5, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-5-2022

Information Regarding Medically Necessary Specialty Infant Formulas: Notice to Health Care Providers

Murilo Freitas - 16:00, 30 de junio de 2022329

The FDA is providing information to health care professionals to help their patients obtain access to medically necessary specialty formulas, the amino acid-based and the metabolic infant formula products.

http://www.fda.gov/safety/medical-product-safety-information/information-regarding-medically-necessary-specialty-infant-formulas-notice-health-care-providers

PRAIS 2.0